Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

From Hope to Infection: Tubo-Ovarian Abscess After Frozen Embryo Transfer-A Case Report and Review of the Literature.

Case reports in obstetrics and gynecology·2026
Same author

Growth factor-free chondrogenesis and immunomodulation of Wharton's jelly MSCs on chitosan-hyaluronic acid films.

Frontiers in bioengineering and biotechnology·2026
Same author

Massive Retroperitoneal Hematoma Following Vaginal Delivery: A Case Report and Review of Literature.

Cureus·2026
Same author

Identifying Chronotype for the Preservation of Muscle Mass, Quality and Strength.

Nutrients·2026
Same author

Occurrence and Health Risk Assessment of Per- and Polyfluoroalkyl Substances in Yogurt Across Lebanese Governorates.

Foods (Basel, Switzerland)·2025
Same author

Investigating PCBs and OCPs in Lebanese Yogurt: National Contamination Patterns and Health Risk Assessment.

Foods (Basel, Switzerland)·2025

Related Experiment Video

Updated: Jun 15, 2025

Generation of a Human iPSC-Based Blood-Brain Barrier Chip
10:20

Generation of a Human iPSC-Based Blood-Brain Barrier Chip

Published on: March 2, 2020

12.4K

Organ-On-A-Chip Devices: Technology Progress and Challenges.

Pierre J Obeid1, Paolo Yammine1, Hanna El-Nakat1

  • 1Department of Chemistry, Faculty of Arts and Sciences, University of Balamand, P.O. Box: 100, Tripoli, Lebanon.

Chembiochem : a European Journal of Chemical Biology
|August 25, 2024
PubMed
Summary

Organ-On-a-Chip (OOC) technology offers a revolutionary approach to drug development and personalized medicine by simulating organ functions. This advanced microfluidic system reduces animal testing and predicts drug efficacy and side effects.

Keywords:
BiomaterialsHuman-on-a-chipMicrofluidic devicesOrgan-on-a-chipSensors and biosensors

More Related Videos

Scalable Fabrication of Stretchable, Dual Channel, Microfluidic Organ Chips
14:44

Scalable Fabrication of Stretchable, Dual Channel, Microfluidic Organ Chips

Published on: October 20, 2018

26.6K
Fabrication and Validation of an Organ-on-chip System with Integrated Electrodes to Directly Quantify Transendothelial Electrical Resistance
10:51

Fabrication and Validation of an Organ-on-chip System with Integrated Electrodes to Directly Quantify Transendothelial Electrical Resistance

Published on: September 26, 2017

16.3K

Related Experiment Videos

Last Updated: Jun 15, 2025

Generation of a Human iPSC-Based Blood-Brain Barrier Chip
10:20

Generation of a Human iPSC-Based Blood-Brain Barrier Chip

Published on: March 2, 2020

12.4K
Scalable Fabrication of Stretchable, Dual Channel, Microfluidic Organ Chips
14:44

Scalable Fabrication of Stretchable, Dual Channel, Microfluidic Organ Chips

Published on: October 20, 2018

26.6K
Fabrication and Validation of an Organ-on-chip System with Integrated Electrodes to Directly Quantify Transendothelial Electrical Resistance
10:51

Fabrication and Validation of an Organ-on-chip System with Integrated Electrodes to Directly Quantify Transendothelial Electrical Resistance

Published on: September 26, 2017

16.3K

Area of Science:

  • Multidisciplinary science integrating microbiology, microfluidics, biomaterials, and bioengineering.

Background:

  • Organ-On-a-Chip (OOC) systems are 3D-microfluidic cell-culture devices that mimic organ functions.
  • OOC technology is pivotal in advancing pharmaceutical research and personalized medicine.

Purpose of the Study:

  • To review the progress and achievements of various OOC technologies.
  • To highlight OOC advantages in reducing animal testing and enabling personalized medical responses.
  • To explore OOC applications in pharmaceutical research for disease treatment and drug development.

Main Methods:

  • Investigation of models used in OOC device construction.
  • Analysis of microfluidic device design and materials.
  • Discussion of integrated monitoring devices (sensors, biosensors) within OOCs.

Main Results:

  • OOC technology significantly reduces animal testing requirements.
  • OOC systems provide personalized medical insights and predict drug effects on target and other organs.
  • OOC models are effective in predicting drug efficacy and potential side effects.

Conclusions:

  • Organ-On-a-Chip is a powerful tool for pharmaceutical research, offering predictive insights into drug actions.
  • The integration of OOCs into preclinical and clinical studies promises to reduce failure rates and enhance drug development.
  • Future advancements in OOC technology and FDA regulations will further establish its role in medical research and personalized healthcare.